Travere Therapeutics's total assets for Q1 2026 were $555.19M, a decrease of -8.26% from the previous quarter. TVTX total liabilities were $456.46M for the fiscal quarter, a -6.91% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.